Search for
Stone Analysis Kidney (Renal) calculus
Kidney
Report in 48Hrs
At Home
No Fasting Required
Details
Determine kidney stones chemical and crystalline composition
₹1,750₹2,250
22% OFF
Stone Analysis Kidney (Renal) Calculus - Comprehensive Medical Test Guide
- Why is it done?
- Test Purpose: Identifies the chemical composition and structure of kidney stones to determine the underlying cause of stone formation
- Primary Indications:
- Patients who have passed or had stones surgically removed and require chemical analysis for composition determination
- Recurrent kidney stone formers requiring preventive treatment strategies based on stone type
- Evaluation of unexplained renal colic or urinary obstruction to guide therapeutic interventions
- Assessment of metabolic disorders causing abnormal stone formation
- Typical Timing: Performed after spontaneous passage of stone, lithotripsy procedure, or surgical stone removal to allow proper laboratory analysis and treatment planning
- Normal Range
- Reference Ranges by Stone Composition:
- Normal: Absence of kidney stone formation; no stone material present for analysis indicates normal urinary composition
- Calcium Oxalate Stones: Most common (70-75% of all stones); composed primarily of calcium oxalate monohydrate or dihydrate crystalline structures
- Magnesium Ammonium Phosphate (Struvite) Stones: 10-15% incidence; typically associated with urinary tract infections; composed of triple phosphate crystals
- Uric Acid Stones: 5-10% occurrence; radiolucent on standard imaging; typically found in gout patients or those with high uric acid levels
- Calcium Phosphate Stones: 5-8% incidence; associated with alkaline urine and renal tubular acidosis
- Cystine Stones: <1% occurrence; associated with inherited cystinuria; characteristic hexagonal crystal appearance
- Units of Measurement: Percentage composition by weight (%), qualitative identification of crystalline components, and morphological description of stone structure
- Interpretation: Positive result indicates stone material present requiring identification of primary and secondary components; normal result indicates absence of calculi or insufficient specimen
- Interpretation
- Calcium Oxalate Stones Detected:
- Indicates hypercalciuria, hyperoxaluria, or decreased citrate levels; requires evaluation for primary hyperparathyroidism, sarcoidosis, vitamin D toxicity, or dietary excess
- Struvite Stones Identified:
- Strongly associated with urease-producing bacterial infections (Proteus, Klebsiella); predisposition to staghorn calculi formation and potential renal damage if untreated
- Uric Acid Stones Present:
- Suggests gout, tumor lysis syndrome, excessive purine intake, chronic diarrhea, or acidic urine; responds well to urine alkalinization therapy
- Calcium Phosphate Composition:
- Associated with renal tubular acidosis, primary hyperparathyroidism, or distal renal tubular acidosis requiring specific therapeutic interventions and urine acidification
- Cystine Stones Confirmation:
- Diagnostic of inherited cystinuria; indicates abnormal amino acid transport requiring aggressive preventive measures including high urine output, urine alkalinization, and potentially chelating agents
- Mixed Composition Stones:
- Frequently observed with calcium oxalate and phosphate combinations; therapeutic approach targets the predominant component while addressing secondary factors
- Factors Affecting Results:
- Specimen quality and completeness; time delay between collection and analysis; contamination during collection process; incomplete stone material recovery
- Associated Organs
- Primary Organ Systems Involved:
- Kidneys and urinary tract system; renal pelvis, ureters, and urethra for stone passage and obstruction complications
- Bladder and prostate involvement in distal stone disease and urinary retention conditions
- Associated Medical Conditions:
- Nephrolithiasis (kidney stone disease) with various compositional etiologies requiring targeted prevention
- Primary hyperparathyroidism causing hypercalcemia and stone formation
- Gout and uric acid metabolism disorders associated with uric acid crystallization
- Recurrent urinary tract infections particularly with urease-producing organisms causing struvite formation
- Renal tubular acidosis causing calcium phosphate stone precipitation
- Cystinuria - autosomal recessive genetic disorder affecting amino acid transport
- Sarcoidosis with associated hypercalcemia and hypercalciuria
- Inflammatory bowel disease causing hyperoxaluria and stone formation
- Potential Complications and Associated Risks:
- Urinary obstruction leading to acute renal failure and hydronephrosis with permanent renal damage if prolonged
- Chronic kidney disease progression from recurrent stone formation and obstruction episodes
- Urosepsis development secondary to infected obstructive stones requiring emergency intervention
- Renal papillary necrosis from chronic stone disease and related urinary tract infections
- Follow-up Tests
- Recommended Subsequent Investigations:
- 24-hour urine collection for measurement of calcium, oxalate, uric acid, citrate, phosphate, and magnesium levels to identify specific metabolic abnormalities
- Serum calcium, phosphate, and parathyroid hormone (PTH) to evaluate for primary hyperparathyroidism
- Serum uric acid and creatinine measurements to assess uric acid metabolism and renal function
- Urine culture and urinalysis to identify urinary tract infections and assess urine pH for stone type correlation
- Cystine-specific urine screening test in cases of cystine stone identification
- Imaging Studies:
- Non-contrast CT scan for detection of recurrent stone formation and assessment of kidney changes
- Renal ultrasound or abdominal radiography for surveillance of stone recurrence and hydronephrosis development
- Specialty Testing:
- Parathyroid imaging and sestamibi scan if primary hyperparathyroidism suspected based on stone composition
- Genetic counseling and DNA testing for cystinuria diagnosis confirmation and family screening
- Monitoring Frequency:
- Initial comprehensive metabolic workup within 4-6 weeks after stone passage or removal
- Annual imaging surveillance for first-time stone formers with baseline metabolic risk factors
- 6-12 month monitoring intervals for recurrent stone formers with targeted metabolic therapy
- Repeat stone analysis if composition changes or recurrent stone formation occurs despite preventive measures
- Fasting Required?
- Fasting Requirement:
- No - Fasting is NOT required for stone analysis itself, as this is direct examination of the physical specimen
- Specimen Collection Requirements:
- Obtain entire stone specimen that has passed spontaneously or been removed surgically with no contamination from urine or other substances
- Allow stone to dry completely before placing in sterile container to prevent degradation or contamination
- Do not wash stone with distilled water or other solutions that may alter composition or dissolve components
- Special Instructions:
- Preserve stone in dry sterile container at room temperature; avoid refrigeration or freezing which may cause crystal changes
- Transport to laboratory promptly after collection, ideally within 24 hours to prevent decomposition
- Maintain proper labeling with patient identification, collection date, and type of collection (passed vs. surgical removal)
- If concurrent metabolic workup needed: Fast for 8-12 hours for serum calcium, PTH, and metabolic panel; 24-hour urine collection required on separate occasion with normal dietary intake
- Medications to Avoid or Report:
- No specific medication restrictions for stone analysis itself; however, report any medications affecting urine composition to laboratory
- For accompanying metabolic studies: Inform physician of diuretics, thiazides, allopurinol, or uricosuric agents affecting test interpretation
- Other Patient Preparation:
- Educate patient on proper stone collection and storage to maximize specimen quality for accurate analysis
- For surgical cases: Ensure urologist or surgical team collects stone before any fixative solutions applied
- Coordinate timing with 24-hour urine collection for complete metabolic evaluation within appropriate test windows
How our test process works!

